Marpai, INC. (MRAI) — 8-K Filings

8-K Filings (25)

• 8-K Filing — Dec 23, 2025
• Marpai, Inc. Files 8-K with Corporate Updates — Oct 20, 2025 Risk: low
  Marpai, Inc. filed an 8-K on October 20, 2025, reporting events as of October 17, 2025. The filing indicates amendments to its Articles of Incorporation or Byla
• Marpai, Inc. Files 8-K: Material Agreement, Equity Sales — Oct 6, 2025 Risk: medium
  On September 30, 2025, Marpai, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also
• Marpai, Inc. Files 8-K: Material Agreement & Equity Sales — Sep 16, 2025 Risk: medium
  Marpai, Inc. announced on September 10, 2025, that it entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity secu
• Marpai, Inc. Reports Board and Officer Changes — Aug 29, 2025 Risk: medium
  Marpai, Inc. filed an 8-K on August 29, 2025, reporting changes in its board of directors and executive officers. The filing details the departure of certain di
• Marpai, Inc. Files 8-K on Security Holder Votes — Aug 27, 2025 Risk: low
  Marpai, Inc. filed an 8-K on August 27, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details abo
• Marpai, Inc. Files 8-K: Material Agreement, Equity Sales — Aug 4, 2025 Risk: medium
  On July 29, 2025, Marpai, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also repor
• Marpai, Inc. Files 8-K for Material Agreement & Equity Sales — Jul 21, 2025 Risk: medium
  On July 17, 2024, Marpai, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with certain investors. The company a
• Marpai, Inc. Files 8-K: Board Changes and Executive Compensation Updates — May 13, 2025 Risk: medium
  On May 12, 2025, Marpai, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the company announced th
• Marpai, Inc. Files 8-K for Material Definitive Agreement — Feb 6, 2025 Risk: medium
  On January 31, 2025, Marpai, Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement or any associated
• Marpai, Inc. Reports Material Definitive Agreement and Equity Sales — Jan 6, 2025 Risk: medium
  On December 30, 2024, Marpai, Inc. entered into a material definitive agreement, which involved the creation of a direct financial obligation. The company also
• Marpai, Inc. Files 8-K: Material Agreement, Equity Sales — Dec 10, 2024 Risk: medium
  On December 5, 2024, Marpai, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also re
• Marpai, Inc. Files 8-K: Material Agreement & Equity Sales — Sep 3, 2024 Risk: medium
  On August 28, 2024, Marpai, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed fi
• Marpai Closes $10M Public Offering — Jun 25, 2024 Risk: medium
  On June 21, 2024, Marpai, Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully raised approximately $10
• Marpai Faces Delisting Concerns — May 24, 2024 Risk: high
  Marpai, Inc. filed an 8-K on May 24, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is addressing its complia
• Marpai Appoints New CMO, Elects Directors — May 14, 2024 Risk: medium
  Marpai, Inc. announced on May 12, 2024, the appointment of Dr. Robert L. Smith as Chief Medical Officer and the election of Dr. Smith and Ms. Jennifer L. Jones
• Marpai Appoints New CMO, Adds Directors — May 6, 2024 Risk: medium
  Marpai, Inc. announced on May 06, 2024, the appointment of Dr. Robert L. Smith as Chief Medical Officer and the election of Dr. Smith and Ms. Sarah E. Johnson t
• Marpai, Inc. Enters Loan Agreement, Reports Equity Sales — Apr 17, 2024 Risk: medium
  On April 15, 2024, Marpai, Inc. entered into a material definitive agreement, specifically a loan agreement with an unnamed lender. This agreement creates a dir
• Marpai, Inc. Files 8-K on Financials — Mar 26, 2024 Risk: low
  On March 26, 2024, Marpai, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, along with finan
• Marpai, Inc. Files 8-K with Financials — Mar 13, 2024 Risk: low
  Marpai, Inc. filed an 8-K on March 13, 2024, reporting an event on March 12, 2024. The filing primarily concerns financial statements and exhibits, with no spec
• Marpai, Inc. Files 8-K: Material Agreement & Equity Sales — Mar 8, 2024 Risk: medium
  Marpai, Inc. announced on March 7, 2024, that it entered into a material definitive agreement. The company also disclosed unregistered sales of equity securitie
• Marpai, Inc. Files 8-K Report — Mar 5, 2024 Risk: low
  On March 5, 2024, Marpai, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating it's an update or disclosure rel
• Marpai Files 8-K on Material Agreement; Details Undisclosed — Feb 8, 2024 Risk: medium
  Marpai, Inc. (MRAI) filed an 8-K on February 8, 2024, reporting an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on February 5,
• Marpai 8-K Signals Potential Leadership/Comp Changes — Jan 18, 2024
  Marpai, Inc. filed an 8-K on January 18, 2024, reporting an event that occurred on January 11, 2024. This filing indicates a current report regarding potential
• Marpai Enters Material Agreement, Sells Unregistered Equity — Jan 17, 2024
  Marpai, Inc. filed an 8-K on January 17, 2024, reporting an "Entry into a Material Definitive Agreement" and "Unregistered Sales of Equity Securities" that occu

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX